{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:02:36Z","timestamp":1791946956383,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA060553"],"award-info":[{"award-number":["P30CA060553"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA222294"],"award-info":[{"award-number":["R37CA222294"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.radonc.2023.109571","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T21:36:56Z","timestamp":1677015416000},"page":"109571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study"],"prefix":"10.1016","volume":"182","author":[{"given":"Indra J.","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe Jay","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choonik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Popple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger K.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Abazeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109571_b0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.semradonc.2008.04.001","article-title":"An overview of hypofractionation and introduction to this issue of seminars in radiation oncology","volume":"18","author":"Timmerman","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0010","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2017.12.288","article-title":"Local control after stereotactic body radiation therapy for liver tumors","volume":"110","author":"Ohri","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ijrobp.2014.03.034","article-title":"A phase 1\/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma","volume":"89","author":"Hong","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0025","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.ijrobp.2010.05.016","article-title":"Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer","volume":"79","author":"Kadoya","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0030","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1200\/JCO.2017.75.5371","article-title":"Comparative toxicities and cost of intensity-modulated radiotherapy, proton radiation, and stereotactic body radiotherapy among younger men with prostate cancer","volume":"36","author":"Pan","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0035","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejmp.2016.03.015","article-title":"Lung stereotactic ablative body radiotherapy: a large scale multi-institutional planning comparison for interpreting results of multi-institutional studies","volume":"32","author":"Giglioli","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2023.109571_b0040","doi-asserted-by":"crossref","unstructured":"Ding C, Solberg TD, Hrycushko B, Xing L, Heinzerling J Timmerman RD. Optimization of normalized prescription isodose selection for stereotactic body radiation therapy: conventional vs robotic linac. Med Phys 2013;40:051705","DOI":"10.1118\/1.4798944"},{"key":"10.1016\/j.radonc.2023.109571_b0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejmp.2015.09.009","article-title":"Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case","volume":"32","author":"Esposito","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2023.109571_b0050","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00066-017-1151-8","article-title":"Planning benchmark study for SBRT of early stage NSCLC : results of the DEGRO working group stereotactic radiotherapy","volume":"10","author":"Moustakis","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2023.109571_b0055","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.radonc.2008.03.007","article-title":"Can protons improve SBRT for lung lesions? dosimetric considerations","volume":"88","author":"Georg","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0060","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/j.prro.2022.03.001","article-title":"Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: an ASTRO safety white paper update","volume":"12","author":"Das","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/483531a","article-title":"Drug development: raise standards for preclinical cancer research","volume":"483","author":"Begley","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.radonc.2023.109571_b0070","doi-asserted-by":"crossref","unstructured":"Freedman LP, Cockburn IM Simcoe TS. The Economics of Reproducibility in Preclinical Research. PLoS Biol 2015;13:e1002165","DOI":"10.1371\/journal.pbio.1002165"},{"key":"10.1016\/j.radonc.2023.109571_b0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1590\/s1806-37562018000000164","article-title":"Internal and external validity: can you apply research study results to your patients?","volume":"44","author":"Patino","year":"2018","journal-title":"J Bras Pneumol"},{"key":"10.1016\/j.radonc.2023.109571_b0080","doi-asserted-by":"crossref","unstructured":"Weber DC, Tomsej M, Melidis C Hurkmans CW. QA makes a clinical trial stronger: evidence-based medicine in radiation therapy. Radiother Oncol 2012;105:4-8","DOI":"10.1016\/j.radonc.2012.08.008"},{"key":"10.1016\/j.radonc.2023.109571_b0085","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/jnci\/djn020","article-title":"Intensity-modulated radiation therapy dose prescription, recording and delivery: patterns of variability among institutions and planning systems","volume":"100","author":"Das","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2023.109571_b0090","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.prro.2016.11.003","article-title":"State of dose prescription and compliance to international standard (ICRU-83) in intensity modulated radiation therapy among academic institutions","volume":"7","author":"Das","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0095","unstructured":"ICRUReport 62, Prescribing, Recording, and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). International Commission on Radiation Units and Measurements, 1999."},{"key":"10.1016\/j.radonc.2023.109571_b0100","unstructured":"ICRUReport 50, Prescribing, Recording, and reporting Photon Beam Therapy. International Commission on Radiation Units and Measurements, 1993."},{"key":"10.1016\/j.radonc.2023.109571_b0105","unstructured":"ICRUReport 83, Prescribing, Recording, and Reporting Intensity-Modulated Photon-Beam Therapy (IMRT)(ICRU Report 83). International Commission on Radiation Units and Measurements, 2010."},{"key":"10.1016\/j.radonc.2023.109571_b0110","unstructured":"ICRUReport 91, Prescribing Recording, and Reporting of Stereotactic Treatments with Small Photon Beams. International Commission on Radiation Units and Measurements, 2017"},{"key":"10.1016\/j.radonc.2023.109571_b0115","doi-asserted-by":"crossref","unstructured":"Eaton DJ, Naismith OF Henry AM. Need for consensus when prescribing stereotactic body radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2015;91:239-241","DOI":"10.1016\/j.ijrobp.2014.09.025"},{"key":"10.1016\/j.radonc.2023.109571_b0120","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00066-017-1214-x","article-title":"Italian medical physicist SBRT group w. time for crowd knowledge-based approach in SBRT planning","volume":"169","author":"Mancosu","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2023.109571_b0125","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijrobp.2022.01.008","article-title":"Planning benchmark study for stereotactic body radiation therapy of liver metastases: results of the DEGRO\/DGMP working group on stereotactic radiation therapy and radiosurgery","volume":"113","author":"Moustakis","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","volume":"124","author":"Guckenberger","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0135","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.radonc.2008.07.025","article-title":"ICRU reference dose in an era of intensity-modulated radiation therapy clinical trials: correlation with planning target volume mean dose and suitability for intensity-modulated radiation therapy dose prescription","volume":"89","author":"Yaparpalvi","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0140","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.prro.2017.08.006","article-title":"Adherence to ICRU-83 reporting recommendations is inadequate in prostate dosimetry studies","volume":"8","author":"Mohan","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0167-8140(93)90146-Y","article-title":"Precision in reporting the dose given in a course of radiotherapy","volume":"29","author":"Dische","year":"1993","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0150","doi-asserted-by":"crossref","unstructured":"Ohri N, Shen X, Dicker AP, Doyle LA, Harrison AS Showalter TN. Radiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trials. J Natl Cancer Inst 2013;105:387-393","DOI":"10.1093\/jnci\/djt001"},{"key":"10.1016\/j.radonc.2023.109571_b0155","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1016\/j.prro.2016.08.007","article-title":"Standardizing dose prescriptions: an ASTRO white paper","volume":"6","author":"Evans","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0160","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2015.01.046","article-title":"Quantifying unnecessary normal tissue complication risks due to suuboptimal planning: a secondary study of RTOG 0126","volume":"92","author":"Moore","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0165","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non-small-cell lung cancer: NRG oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0170","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.prro.2022.02.006","article-title":"How 3 academic centers prescribe stereotactic body radiation therapy for primary lung cancer","volume":"12","author":"De Leo","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0175","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.1002\/lary.28083","article-title":"Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer","volume":"130","author":"White","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2023.109571_b0180","article-title":"Prospective phase 2 study of radiation therapy dose and volume de-escalation for elective neck treatment of oropharyngeal and laryngeal cancer","author":"Sher","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0185","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/annonc\/mdy522","article-title":"OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer","volume":"30","author":"Seiwert","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejca.2016.09.006","article-title":"Treatment de-intensification strategies for head and neck cancer","volume":"68","author":"Kelly","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.109571_b0195","doi-asserted-by":"crossref","unstructured":"Ding C, Chang CH, Haslam J, Timmerman R Solberg T. A dosimetric comparison of stereotactic body radiation therapy techniques for lung cancer: robotic versus conventional linac-based systems. J Appl Clin Med Phys 2010;11:3223.","DOI":"10.1120\/jacmp.v11i3.3223"},{"key":"10.1016\/j.radonc.2023.109571_b0200","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.radonc.2020.10.002","article-title":"The role of computational methods for automating and improving clinical target volume definition","volume":"153","author":"Unkelbach","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0205","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2017.12.013","article-title":"American association of physicists in medicine task group 263: standardizing nomenclatures in radiation oncology","volume":"100","author":"Mayo","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0210","doi-asserted-by":"crossref","unstructured":"Desai DD, Johnson EL Cordrey IL. An analytical expression for R50% dependent on PTV surface area and volume: A cranial SRS comparison. J Appl Clin Med Phys 2021;22:203-210","DOI":"10.1002\/acm2.13168"},{"key":"10.1016\/j.radonc.2023.109571_b0215","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/02841869309093624","article-title":"Target dose versus extratarget dose in stereotactic radiosurgery","volume":"32","author":"Lax","year":"1993","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/acm2.13113","article-title":"Cleaning the dose falloff in lung SBRT plan","volume":"22","author":"Desai","year":"2021","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0225","doi-asserted-by":"crossref","unstructured":"Hoffman D, Dragojevi\u0107 I, Hoisak J, Hoopes D Manger R. Lung Stereotactic Body Radiation Therapy (SBRT) dose gradient and PTV volume: a retrospective multi-center analysis. Radiat Oncol 2019;14:162.","DOI":"10.1186\/s13014-019-1334-9"},{"key":"10.1016\/j.radonc.2023.109571_b0230","doi-asserted-by":"crossref","unstructured":"Widder J, Hollander M, Ubbels JF, Bolt RA Langendijk JA. Optimizing dose prescription in stereotactic body radiotherapy for lung tumours using Monte Carlo dose calculation. Radiother Oncol 2010;94:42-46","DOI":"10.1016\/j.radonc.2009.11.008"},{"key":"10.1016\/j.radonc.2023.109571_b0235","doi-asserted-by":"crossref","unstructured":"Fontenot JD, King ML, Johnson SA, Wood CG, Price MJ Lo KK. Single-arc volumetric-modulated arc therapy can provide dose distributions equivalent to fixed-beam intensity-modulated radiation therapy for prostatic irradiation with seminal vesicle and\/or lymph node involvement. Br J Radiol 2012;85:231-236","DOI":"10.1259\/bjr\/94843998"},{"key":"10.1016\/j.radonc.2023.109571_b0240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijrobp.2009.05.038","article-title":"Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes","volume":"76","author":"Popescu","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0245","doi-asserted-by":"crossref","first-page":"e886","DOI":"10.1002\/mp.15030","article-title":"Report of AAPM task group 155: megavoltage photon beam dosimetry in small fields and non-equilibrium conditions","volume":"48","author":"Das","year":"2021","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0250","unstructured":"IAEA TRS 483, Dosimetry of small static fields used in external beam radiotherapy: An IAEA-AAPM International Code of Practice for reference and relative dose determination, Technical Report Series No. 483. International Atomic Energy Agency, 2017."},{"key":"10.1016\/j.radonc.2023.109571_b0255","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00066-018-1383-2","article-title":"SBRT planning for spinal metastasis: indications from a large multicentric study","volume":"195","author":"Esposito","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2023.109571_b0260","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijrobp.2019.10.041","article-title":"Dosimetric multicenter planning comparison studies for stereotactic body radiation therapy: methodology and future perspectives","volume":"106","author":"Giglioli","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0265","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1016\/j.prro.2017.04.018","article-title":"Dose dissonance in radiation oncology: Consensus needed when prescribing dose in radiation therapy","volume":"7","author":"Schiff","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0270","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s00066-017-1216-8","article-title":"Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches","volume":"193","author":"Moustakis","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2023.109571_b0275","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.ijrobp.2011.10.078","article-title":"Critical appraisal of Acuros XB and anisotropic analytic algorithm dose calculation in advanced non-small-cell lung cancer treatments","volume":"83","author":"Fogliata","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0280","doi-asserted-by":"crossref","unstructured":"Ojala JJ, Kapanen MK, Hyodynmaa SJ, Wigren TK Pitkanen MA. Performance of dose calculation algorithms from three generations in lung SBRT: comparison with full Monte Carlo-based dose distributions. J Appl Clin Med Phys 2014;15:4662.","DOI":"10.1120\/jacmp.v15i2.4662"},{"key":"10.1016\/j.radonc.2023.109571_b0285","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/jcm12030906","article-title":"SP Das IJ. Variability of Low-Z Inhomogeneity Correction in IMRT\/SBRT: A Multi-Institutional Collaborative Study","volume":"12","author":"Yadav","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.radonc.2023.109571_b0290","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1118\/1.3579139","article-title":"Report of AAPM TG 135: quality assurance for robotic radiosurgery","volume":"38","author":"Dieterich","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0295","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2023.109571_b0300","doi-asserted-by":"crossref","unstructured":"Srivastava SP, Cheng CW Das IJ. The dosimetric and radiobiological impact of calculation grid size on head and neck IMRT. Pr Radiat Oncol 2017;7:209-217","DOI":"10.1016\/j.prro.2016.10.001"},{"key":"10.1016\/j.radonc.2023.109571_b0305","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2019.11.001","article-title":"Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91","volume":"142","author":"de Jong","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0310","doi-asserted-by":"crossref","unstructured":"Das IJ, Yadav P Mittal BB. Emergence of MR-Linac in Radiation Oncology: Successes and Challenges of Riding on the MRgRT Bandwagon. J Clin Med 2022;11","DOI":"10.3390\/jcm11175136"},{"key":"10.1016\/j.radonc.2023.109571_b0315","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2021.12.018","article-title":"An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer","volume":"167","author":"Sheikh","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0320","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.radonc.2015.09.008","article-title":"Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy","volume":"118","author":"Guckenberger","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0325","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.radonc.2014.04.015","article-title":"Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071\u201324071 prospective study for head and neck cancer","volume":"111","author":"Weber","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109571_b0330","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023001093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023001093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:26:02Z","timestamp":1759123562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":66,"alternative-id":["S0167814023001093"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109571","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109571"}}